- Home
- TRAW vs CHRO Comparison
TRAW vs CHRO Comparison
Compare TRAW & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- CHRO
- Stock Information
- Founded
- TRAW 1998
- CHRO 2002
- Country
- TRAW United States
- CHRO United States
- Employees
- TRAW N/A
- CHRO N/A
- Industry
- TRAW
- CHRO
- Sector
- TRAW
- CHRO
- Exchange
- TRAW NYSE
- CHRO Nasdaq
- Market Cap
- TRAW 10.1M
- CHRO 10.7M
- IPO Year
- TRAW 2013
- CHRO 2024
- Fundamental
- Price
- TRAW $2.16
- CHRO $1.40
- Analyst Decision
- TRAW
- CHRO Strong Buy
- Analyst Count
- TRAW 0
- CHRO 1
- Target Price
- TRAW N/A
- CHRO N/A
- AVG Volume (30 Days)
- TRAW 48.8K
- CHRO 8.2K
- Earning Date
- TRAW 03-31-2025
- CHRO 03-27-2025
- Dividend Yield
- TRAW N/A
- CHRO N/A
- EPS Growth
- TRAW N/A
- CHRO N/A
- EPS
- TRAW N/A
- CHRO N/A
- Revenue
- TRAW $226,000.00
- CHRO N/A
- Revenue This Year
- TRAW $3.81
- CHRO N/A
- Revenue Next Year
- TRAW N/A
- CHRO N/A
- P/E Ratio
- TRAW N/A
- CHRO N/A
- Revenue Growth
- TRAW N/A
- CHRO N/A
- 52 Week Low
- TRAW $2.01
- CHRO $0.45
- 52 Week High
- TRAW $24.75
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- TRAW 28.66
- CHRO 42.11
- Support Level
- TRAW $2.01
- CHRO $1.33
- Resistance Level
- TRAW $2.51
- CHRO $1.58
- Average True Range (ATR)
- TRAW 0.27
- CHRO 0.17
- MACD
- TRAW 0.07
- CHRO -0.02
- Stochastic Oscillator
- TRAW 7.63
- CHRO 11.94
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.